Mechanism of Drug–Drug Interactions Mediated by Human Cytochrome P450 CYP3A4 Monomer

Biochemistry- United States

doi 10.1021/acs.biochem.5b00079

Full Text

Abstract

Available in

Categories

Date

March 25, 2015

Authors

Ilia G. Denisov

Yelena V. Grinkova

Javier L. Baylon

Emad Tajkhorshid

Stephen G. Sligar

Publisher

American Chemical Society (ACS)

Related search

Drug-Drug Interactions Between Atorvastatin and Dronedarone Mediated by Monomeric CYP3A4

English

Cytochrome P450 Drug Interactions With Statin Therapy

Singapore Medical Journal

English

Retraction: Role of Cytochrome P450 in Drug Interactions

Nutrition and Metabolism

English

African Genetic Diversity: Implications for Cytochrome P450-Mediated Drug Metabolism and Drug Development

Molecular Biology

English

Correction to “Allosteric Interactions in Human Cytochrome P450 CYP3A4: The Role of Phenylalanine 213”

English

In Vitro Drug–drug Interactions of Budesonide: Inhibition and Induction of Transporters and Cytochrome P450 Enzymes

English

Perpetrators of Pharmacokinetic Drug-Drug Interactions Arising From Altered Cytochrome P450 Activity: A Criteria-Based Assessment

British Journal of Clinical Pharmacology

English

Influence of Various Polymorphic Variants of Cytochrome P450 Oxidoreductase (POR) on Drug Metabolic Activity of CYP3A4 and CYP2B6

Multidisciplinary

English

Plasma Exosomes and Drug Metabolic Cytochrome P450 Enzymes

Journal of Drug Metabolism & Toxicology

English